AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration Sweden

Research

Date range: 1 June 2021 - 31 May 2022

Research collaboration: AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions.


Relationships

Partner Institutions

AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs